C2C Advanced Systems Limited...
16 Nov 2024
Medicamen Organics Limited IPO
Medicamen Organics Limited is engaged in developing, manufacturing and distributing a broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. They have a track record of operating a B2B model which covers the contract manufacturing model. Their manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified staff to facilitate a smooth manufacturing process. Medicamen Organics IPO is a book-built issue of Rs 10.54 crores.
The issue is entirely a fresh issue of 31 lakh shares. Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. The allotment for the Medicamen Organics IPO is expected to be finalized on Wednesday, June 26, 2024. Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. GYR Capital Advisors Private Limited is the book-running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Medicamen Organics IPO is Giriraj Stock Broking.
Medicamen Organics IPO Overview
| Detail | Description |
|---|---|
| IPO Date | June 21, 2024 to June 25, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹32 to ₹34 per share |
| Lot Size | 4000 Shares |
| Total Issue Size | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Fresh Issue | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 8,600,000 |
| Share holding post issue | 11,700,000 |
| Market Maker portion | 172,000 shares |
Medicamen Organics IPO Timeline (Tentative Schedule)
| Detail | Description |
|---|---|
| IPO Open Date | Friday, June 21, 2024 |
| IPO Close Date | Tuesday, June 25, 2024 |
| Basis of Allotment | Wednesday, June 26, 2024 |
| Initiation of Refunds | Thursday, June 27, 2024 |
| Credit of Shares to Demat | Thursday, June 27, 2024 |
| Listing Date | Friday, June 28, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 25, 2024 |
Medicamen Organics IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |
Medicamen Organics IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
Medicamen Organics IPO Promoter Holding
| Share Holding Pre Issue | 81.21% |
| Share Holding Post Issue |
Medicamen Organics IPO Anchor Investors Details
| Bid Date | June 20, 2024 |
| Shares Offered | 876,000 |
| Anchor Portion Size (In Cr.) | 2.98 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 26, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 24, 2024 |
Company & Financials
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer. The company's product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDs). The company's products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors. The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
Medicamen Organics Limited Financial Information
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 | ||||||||||||||||||||||||||||||||||||
| Assets | 3,858.07 | 3,211.98 | 2,707.21 | 2,634.37 | ||||||||||||||||||||||||||||||||||||
| Revenue | 2,528.96 | 2,296.24 | 2,118.67 | 2,505.96 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 240.41 | 95.78 | 9.23 | 29.81 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 1,518.40 | 851.71 | 755.92 | 746.72 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 658.40 | 251.71 | 155.92 | 146.72 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 1,265.65 | 1,179.50 | 1,024.57 | 958.97 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Lakhs | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt/Equity | 0.83 |
| RoNW | 15.83 |
| P/BV | 2.39 |
| PAT Margin (%) | 9.51 |
Objectives of Medicamen Organics IPO
The company proposes to utilize the Net Proceeds from the Issue towards the following objectives:
- 1. Funding of expenses proposed to be incurred towards Product registration in the international markets;
- 2. Plant updation and increase in production capacity;
- 3. Funding working capital requirements of our Company; and
- 4. General Corporate Purposes.
Medicamen Organics IPO Review
The company is operating in a highly competitive and fragmented segment of Pharma products. It posted average financial performance for the reported periods with a boosted bottom line for FY24. Based on FY24 earnings, the issue appears fully priced. Well-informed investors may park moderate funds for long-term rewards.
FAQs for Medicamen Organics IPO
-
What is Medicamen Organics IPO?
Medicamen Organics IPO is an NSE SME IPO. They are going to raise ₹10.54 Crores via IPO. The issue is priced at ₹32 to ₹34 per equity share. The IPO is to be listed on NSE.
-
When will Medicamen Organics IPO?
The IPO is to open on June 21, 2024, for QIB, NII, and Retail Investors.
-
What is Medicamen Organics IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Medicamen Organics IPO Size?
Medicamen Organics IPO size is ₹10.54 crores.
-
What is Medicamen Organics IPO Price Band?
Medicamen Organics IPO Price Band is ₹32 to ₹34 per equity share.
-
What is Medicamen Organics IPO Minimum and Maximum Lot Size?
The IPO bid is 4000 shares with ₹136,000.
-
What is Medicamen Organics IPO Allotment Date?
Medicamen Organics IPO allotment date is June 26, 2024.
-
What is Medicamen Organics IPO Listing Date?
Medicamen Organics IPO listing date is June 28, 2024. The IPO to list on NSE SME.
RHP:
RHP of Medicamen Organics Limited IPO
DRHP:
DRHP of Medicamen Organics Limited IPO
Anchor Investor Link:
Anchor Investor Link of Medicamen Organics Limited IPO
-
What is Medicamen Organics IPO?
Medicamen Organics IPO is an NSE SME IPO. They are going to raise ₹10.54 Crores via IPO. The issue is priced at ₹32 to ₹34 per equity share. The IPO is to be listed on NSE.
-
When will Medicamen Organics IPO?
The IPO is to open on June 21, 2024, for QIB, NII, and Retail Investors.
-
What is Medicamen Organics IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Medicamen Organics IPO Size?
Medicamen Organics IPO size is ₹10.54 crores.
-
What is Medicamen Organics IPO Price Band?
Medicamen Organics IPO Price Band is ₹32 to ₹34 per equity share.
-
What is Medicamen Organics IPO Minimum and Maximum Lot Size?
The IPO bid is 4000 shares with ₹136,000.
-
What is Medicamen Organics IPO Allotment Date?
Medicamen Organics IPO allotment date is June 26, 2024.
-
What is Medicamen Organics IPO Listing Date?
Medicamen Organics IPO listing date is June 28, 2024. The IPO to list on NSE SME.
Read More IPO related blogs- Winny Immigration and Education Services Limited IPO
_Limited_IPO_right.jpg)
_Limited_IPO_right.jpg)
_Mobility_&_Hospitality_Limited_IPO_right.jpg)
